NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,330,388 | -48.7% | 825,411 | +31.9% | 0.00% | -66.7% |
| Q2 2023 | $25,963,894 | +86.9% | 625,636 | +170.8% | 0.01% | +100.0% |
| Q1 2023 | $13,893,122 | -59.7% | 231,013 | -50.8% | 0.00% | -62.5% |
| Q4 2022 | $34,474,867 | -3.1% | 470,005 | +0.4% | 0.01% | 0.0% |
| Q3 2022 | $35,583,000 | -36.4% | 468,336 | -41.8% | 0.01% | -42.9% |
| Q2 2022 | $55,964,000 | +8.4% | 805,224 | +29.3% | 0.01% | +27.3% |
| Q1 2022 | $51,614,000 | +41.9% | 622,977 | +28.6% | 0.01% | +37.5% |
| Q4 2021 | $36,374,000 | -35.9% | 484,469 | -0.8% | 0.01% | -27.3% |
| Q3 2021 | $56,720,000 | -32.0% | 488,254 | +29.8% | 0.01% | -42.1% |
| Q2 2021 | $83,438,000 | +98.4% | 376,149 | +18.2% | 0.02% | +90.0% |
| Q1 2021 | $42,053,000 | -39.7% | 318,144 | -21.0% | 0.01% | -44.4% |
| Q4 2020 | $69,695,000 | +17.3% | 402,767 | -24.6% | 0.02% | 0.0% |
| Q3 2020 | $59,422,000 | +201.3% | 533,849 | +60.5% | 0.02% | +157.1% |
| Q2 2020 | $19,720,000 | -2.4% | 332,537 | +10.9% | 0.01% | -22.2% |
| Q1 2020 | $20,196,000 | +22.3% | 299,912 | +53.1% | 0.01% | +28.6% |
| Q4 2019 | $16,514,000 | +42.4% | 195,956 | +26.4% | 0.01% | +16.7% |
| Q3 2019 | $11,595,000 | +112.4% | 155,051 | +79.6% | 0.01% | +100.0% |
| Q2 2019 | $5,459,000 | -35.0% | 86,353 | -50.5% | 0.00% | -25.0% |
| Q1 2019 | $8,395,000 | -16.5% | 174,291 | -41.9% | 0.00% | -20.0% |
| Q4 2018 | $10,050,000 | +33.4% | 300,216 | +108.8% | 0.01% | +66.7% |
| Q3 2018 | $7,536,000 | -66.8% | 143,805 | -80.1% | 0.00% | -72.7% |
| Q2 2018 | $22,668,000 | -17.4% | 724,236 | -42.4% | 0.01% | -26.7% |
| Q1 2018 | $27,427,000 | +166.6% | 1,258,087 | +147.0% | 0.02% | +150.0% |
| Q4 2017 | $10,287,000 | +139.0% | 509,262 | +134.8% | 0.01% | +50.0% |
| Q3 2017 | $4,305,000 | +260.6% | 216,865 | +214.3% | 0.00% | +300.0% |
| Q2 2017 | $1,194,000 | +509.2% | 69,004 | +184.1% | 0.00% | – |
| Q1 2017 | $196,000 | +49.6% | 24,291 | +45.3% | 0.00% | – |
| Q4 2016 | $131,000 | -49.8% | 16,722 | -7.4% | 0.00% | – |
| Q1 2016 | $261,000 | – | 18,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |